PureTech Health Financials
| PRTC Stock | 131.00 1.80 1.39% |
PureTech | Select Account or Indicator |
Please note, the imprecision that can be found in PureTech Health's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of PureTech Health plc. Check PureTech Health's Beneish M Score to see the likelihood of PureTech Health's management manipulating its earnings.
PureTech Health Stock Summary
PureTech Health competes with Universal Display, JD Sports, Ecclesiastical Insurance, Concurrent Technologies, and MTI Wireless. PureTech Health is entity of United Kingdom. It is traded as Stock on LSE exchange.| Foreign Associate | USA |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | UK Stock View All |
| Exchange | London Exchange |
| ISIN | GB00BY2Z0H74 |
| Business Address | 6 Tide Street, |
| Sector | Life Sciences Tools & Services |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.puretechhealth.com |
| Phone | 617 482 2333 |
You should never invest in PureTech Health without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of PureTech Stock, because this is throwing your money away. Analyzing the key information contained in PureTech Health's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
PureTech Health Key Financial Ratios
There are many critical financial ratios that PureTech Health's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that PureTech Health plc reports annually and quarterly.| Revenue | 750 K | ||||
| Gross Profit | (81.55 M) | ||||
| EBITDA | (17.68 M) | ||||
| Net Income | (66.63 M) | ||||
| Total Asset | 693.97 M |
PureTech Health Key Balance Sheet Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Total Assets | 990.0M | 946.0M | 702.6M | 694.0M | 798.1M | 544.9M | |
| Other Current Liab | 141.1M | 205.3M | 57.9M | 29.6M | 34.1M | 32.4M | |
| Other Liab | 116.7M | 108.6M | 92.4M | 23.8M | 27.3M | 36.5M | |
| Net Debt | (327.3M) | (413.7M) | (103.0M) | (165.7M) | (149.2M) | (156.6M) | |
| Retained Earnings | 260.4M | 199.9M | 149.5M | 83.8M | 96.4M | 101.2M | |
| Accounts Payable | 8.9M | 11.3M | 26.5M | 14.6M | 16.8M | 17.7M | |
| Cash | 403.9M | 465.7M | 149.9M | 191.1M | 219.7M | 180.3M | |
| Other Assets | 819K | 2.3M | 1K | 2.1M | 1.2K | 1.1K | |
| Net Receivables | 2.9M | 3.6M | 12.3M | 2.4M | 2.7M | 3.0M | |
| Other Current Assets | 7.5M | 32.5M | 23.8M | 17.7M | 20.3M | 10.7M | |
| Total Liab | 336.5M | 361.9M | 155.1M | 235.7M | 271.1M | 223.8M | |
| Total Current Assets | 414.3M | 501.8M | 386.2M | 347.2M | 399.3M | 287.1M | |
| Short Term Debt | 29.7M | 9.4M | 12.5M | 7.1M | 8.2M | 8.6M | |
| Intangible Assets | 899K | 987K | 831K | 906K | 815.4K | 774.6K | |
| Common Stock | 5.4M | 5.4M | 5.5M | 5.5M | 4.9M | 4.7M | |
| Net Tangible Assets | 667.4M | 668.8M | 592.5M | 541.4M | 622.6M | 369.1M | |
| Short Long Term Debt | 26.5M | 4.8M | 7.5M | 3.7M | 4.3M | 4.0M | |
| Net Invested Capital | 711.0M | 612.5M | 560.0M | 467.8M | 537.9M | 554.7M | |
| Net Working Capital | 233.4M | 275.7M | 289.3M | 295.8M | 340.2M | 357.2M |
PureTech Health Key Income Statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Interest Expense | 2.9M | 4.7M | 4.0M | 13.5M | 15.5M | 16.3M | |
| Total Revenue | 8.3M | 10.0M | 2.1M | 750K | 675K | 641.3K | |
| Gross Profit | 8.3M | (100.5M) | (150.3M) | (95.5M) | (85.9M) | (81.6M) | |
| Operating Income | (119.5M) | (150.3M) | (197.8M) | (146.2M) | (131.6M) | (138.2M) | |
| Ebit | (151.4M) | (54.2M) | (88.8M) | (22.6M) | (20.4M) | (21.4M) | |
| Research Development | 61.2M | 81.5M | 116.1M | 96.2M | 110.7M | 56.3M | |
| Ebitda | (144.8M) | (47.0M) | (79.9M) | (17.7M) | (15.9M) | (16.7M) | |
| Income Before Tax | 19.0M | (59.0M) | (92.8M) | (36.1M) | (41.5M) | (39.4M) | |
| Net Income | 4.6M | (62.7M) | (37.1M) | (65.7M) | (75.6M) | (71.8M) | |
| Income Tax Expense | 14.4M | 3.8M | (55.7M) | 30.5M | 35.1M | 36.9M | |
| Minority Interest | (16.2M) | 2.2M | (13.3M) | 931K | 1.1M | 1.1M | |
| Tax Provision | 14.4M | 3.8M | (55.7M) | 30.5M | 27.5M | 28.8M | |
| Net Interest Income | (1.8M) | (4.5M) | 1.8M | 2.5M | 2.9M | 3.0M | |
| Interest Income | 1.2M | 214K | 5.8M | 16.0M | 18.4M | 19.3M |
PureTech Health Key Cash Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change In Cash | 271.5M | 61.8M | (315.8M) | 41.2M | 37.1M | 38.9M | |
| Free Cash Flow | (137.3M) | (163.9M) | (181.0M) | (106.2M) | (95.5M) | (100.3M) | |
| Depreciation | 6.6M | 7.3M | 8.9M | 4.9M | 5.7M | 3.9M | |
| Other Non Cash Items | 6.1M | (5.1M) | (181.2M) | (62.6M) | (56.3M) | (53.5M) | |
| Dividends Paid | 1.1M | 112K | 6.0M | 4.0M | 4.6M | 4.9M | |
| Capital Expenditures | 5.4M | 5.7M | 2.2M | 245K | 281.8K | 267.7K | |
| Net Income | 4.6M | (62.7M) | (37.1M) | (66.6M) | (76.6M) | (72.8M) | |
| End Period Cash Flow | 403.9M | 465.7M | 149.9M | 191.1M | 219.7M | 165.9M | |
| Investments | 369.6M | 197.4M | (107.2M) | 69.0M | 79.3M | 48.9M | |
| Net Borrowings | 6.0M | (250K) | 36.9M | (1.2M) | (1.3M) | (1.3M) | |
| Change To Netincome | (41.9M) | (541.0M) | (135.9M) | (105.9M) | (95.3M) | (100.0M) |
PureTech Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining PureTech Health's current stock value. Our valuation model uses many indicators to compare PureTech Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across PureTech Health competition to find correlations between indicators driving PureTech Health's intrinsic value. More Info.PureTech Health plc is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the PureTech Health's earnings, one of the primary drivers of an investment's value.PureTech Health plc Systematic Risk
PureTech Health's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. PureTech Health volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on PureTech Health plc correlated with the market. If Beta is less than 0 PureTech Health generally moves in the opposite direction as compared to the market. If PureTech Health Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one PureTech Health plc is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of PureTech Health is generally in the same direction as the market. If Beta > 1 PureTech Health moves generally in the same direction as, but more than the movement of the benchmark.
PureTech Health plc Total Assets Over Time
PureTech Health Thematic Clasifications
PureTech Health plc is part of several thematic ideas from Health Management to IT. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Get More Thematic IdeasPureTech Health March 24, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of PureTech Health help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of PureTech Health plc. We use our internally-developed statistical techniques to arrive at the intrinsic value of PureTech Health plc based on widely used predictive technical indicators. In general, we focus on analyzing PureTech Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build PureTech Health's daily price indicators and compare them against related drivers.
| Information Ratio | (0.17) | |||
| Maximum Drawdown | 7.3 | |||
| Value At Risk | (3.71) | |||
| Potential Upside | 2.64 |
Additional Tools for PureTech Stock Analysis
When running PureTech Health's price analysis, check to measure PureTech Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PureTech Health is operating at the current time. Most of PureTech Health's value examination focuses on studying past and present price action to predict the probability of PureTech Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PureTech Health's price. Additionally, you may evaluate how the addition of PureTech Health to your portfolios can decrease your overall portfolio volatility.